Company Filing History:
Years Active: 2015-2018
Title: Innovations by Erik Meyer in Nucleic Acid Isolation
Introduction
Erik Meyer is an accomplished inventor based in Princeton, NJ (US). He has made significant contributions to the field of molecular biology, particularly in the isolation and purification of nucleic acids from biological samples. With a total of 2 patents, his work has the potential to enhance diagnostic methods and improve sample handling in various applications.
Latest Patents
Meyer’s latest patents focus on compositions, methods, and kits for isolating nucleic acids from body fluids using anion exchange media. The first patent provides compositions and methods for rapid separation, isolation, and purification of nucleic acids from biological samples. This method utilizes commercially available strong or weak anion exchanger materials with selected solutions of known ionic strength for adsorption and elution. It is particularly advantageous as it allows for the purification and identification of shorter fragments of nucleic acids from bodily fluids, which had not been identified until now.
The second patent also addresses the isolation and purification of nucleopolymers from biological samples using anionic exchange media. This method can utilize commercially available anion exchanger materials with selected solutions of known ionic strength for absorption and elution. The medium/nucleoprotein bound complex may be stored or transported, and subsequently treated with eluents to remove undesirable proteins and inorganic salts. This method is beneficial as it allows for rapid isolation and purification of soluble nucleic acids from large volumes of biological fluids, stabilizing the samples against degradation prior to analysis.
Career Highlights
Erik Meyer is currently associated with Trovagene, Inc., where he continues to innovate in the field of nucleic acid research. His work has been instrumental in developing methods that enhance the efficiency and effectiveness of nucleic acid isolation.
Collaborations
Meyer has collaborated with notable colleagues, including Hovsep S Melkonyan and William John Feaver. Their combined expertise has contributed to the advancement of methodologies in molecular biology.
Conclusion
Erik Meyer’s contributions to the field of nucleic acid isolation through his innovative patents have the potential to significantly impact diagnostic methods and biological research. His work exemplifies the importance of innovation in advancing scientific understanding and practical applications.